Block and unblock by imipramine of cloned and mutated P2X2 receptor/channel expressed in Xenopus oocytes

Neuroscience Letters

Volumn 264, Issue 1-3, 1999, Pages 93-96

  Nakazawa, Ken ^a   Inoue, Kazuhide ^a   Ohno, Yasuo ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

ATP; Channel pore; Imipramine; Membrane current; P2X2 receptor channel; Site directed mutagenesis; Voltage clamp

Indexed keywords

IMIPRAMINE; PURINE P2X RECEPTOR;

ANIMAL CELL; ARTICLE; CHANNEL GATING; DEPRESSION; DRUG EFFECT; DRUG RECEPTOR BINDING; NONHUMAN; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; XENOPUS;

ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CLONING, MOLECULAR; ELECTRIC CONDUCTIVITY; FEMALE; IMIPRAMINE; ION CHANNELS; MUTATION; OOCYTES; OSMOLAR CONCENTRATION; PATCH-CLAMP TECHNIQUES; RATS; RECEPTORS, PURINERGIC P2; XENOPUS;

EID: 0033515778     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00183-4     Document Type: Article

References (19)

1. Brake A.J., Wagenbach M.J., Julius D. New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor. Nature. 371:1994;519-523.
2. Buisson B., Bertrand D. Allosteric modulation of neuronal nicotinic acetylcholine receptors. J. Physiol. (Paris). 92:1988;89-100.
3. Choi J.J., Huang G.J., Shafik E., Wu W.H., McArdle J.J. Imipramine's selective suppression of an L-type calcium channel in neurons of murine dorsal root ganglia involves G proteins. J. Pharmacol. Exp. Ther. 263:1992;49-53.
4. 2 receptors identified by the substituted cysteine accessibility method. J. Neurosci. 18:1998;2350-2359.
5. 3 receptors in rat nodose ganglion neurons. Br. J. Pharmacol. 112:1994;741-744.
6. + channels by imipramine in guinea-pig cardiac ventricular cells. J. Pharmacol. Exp. Ther. 256:1991;1072-1081.
7. Koizumi S., Uneyama H., Ikeda M., Ueno S., Inoue K. Inhibition by imipramine of ATP-evoked responses in rat pheochromocytoma cells. Biochem. Biophys. Res. Commun. 244:1998;342-346.
8. Krause R.M., Buisson B., Bertrand S., Corringer P.-J., Galzi J.-L., Changeux J.-P., Bertrand D. Ivermectin: a positive allosteric effector of the α7 neuronal nicotinic acetylcholine receptor. Mol. Pharmacol. 53:1998;283-294.
9. Nakazawa K., Ohno Y. Dopamine and 5-hydroxytryptamine selectively potentiate neuronal type ATP-receptor channels. Eur. J. Pharmacol. 296:1996;119-122.
10. Nakazawa K., Ohno Y. Effects of neuroamines and divalent cations on cloned and mutated ATP-gated channels. Eur. J. Pharmacol. 325:1997;101-108.
11. 2 receptor/channels. Eur. J. Pharmacol. 347:1998;141-144.
12. Nakazawa K., Ohno Y., Inoue K. An aspartic acid residue near the second transmembrane segment of ATP receptor/channel regulates agonist sensitivity. Biochem. Biophys. Res. Commun. 244:1998;599-603.
13. Newbolt A., Stoop R., Virginio C., Surprenant A., North R.A., Buell G., Rassendren F. Membrane topology of an ATP-gated ion channel (P2X receptor). J. Biol. Chem. 273:1998;15177-15182.
14. 3 receptors form stable trimers: a novel structural motif of ligand-gated ion channels. EMBO J. 17:1998;3016-3028.
15. Palma E., Mileo A.M., Eusebi F., Miledi R. Threonine-for-leucine mutation within domain M2 of the neuronal α7 nicotinic receptor converts 5-hydroxytryptamine from agonist to antagonist. Proc. Natl. Acad. Sci. USA. 93:1996;11231-11235.
16. Rana B., McMorn S.O., Reeve H.L., Wyatt C.N., Vaughan P.F.T., Peers C. Inhibition of neuronal nicotinic acetylcholine receptors by imipramine and desipramine. Eur. J. Pharmacol. 250:1993;247-251.
17. Rassendren F., Buell G., Newbolt A., North R.A., Surprenant A. Identification of amino acid residues contributing to the pore of a P2X receptor. EMBO J. 16:1997;3446-3454.
18. 2+ of rat cortical neurons. Eur. J. Pharmacol. 261:1994;65-71.
19. 2 receptor subunit. FEBS Lett. 425:1998;19-23.